Herantis Pharma plc shares subscribed with option rights
Herantis Pharma plc. Stock exchange release 10 November 2014, 11.00 am 4000 new shares of Herantis Pharma plc. have been subscribed with option rights of the option program 2010. New shares have been registered into the Trade Register on 10 November 2014, as of which date the new shares will establish shareholder rights. The share capital will not increase with subscriptions. The entire subscription price of EUR 0.20 will be entered in the invested unrestricted equity reserve of the company. As a result of the share subscriptions, the number of shares of Herantis Pharma plc. will increase to 4,062,214 shares. The new shares will be traded on the NASDAQ OMX Helsinki Ltd's First North marketplace together with the old shares as of 10 November 2014. Share information of the Herantis Pharma plc. share after the registration of new shares: Trading Code: HRTIS ISIN code: FI4000087861 List: First North Helsinki Industry: Health Care Number of Shares: 4,062,214 Share Capital: 80,000.00 euro Herantis Pharma plc. Pekka Simula CEO Further information: Herantis Pharma plc., Pekka Simula, CEO, telephone: +358 40 7300 445 Company web site: www.herantis.com Certified Advisor: UB Capital Oy, telephone: +358 9 2538 0225 About Herantis Pharma plc. Herantis Pharma plc. is a pharmaceutical company specialised in new drug research and development. The company focuses on diseases with an unmet clinical need. These diseases include for example dry eye syndrome, Parkinson's disease, and secondary lymphedema. We believe our drugs are the first or best in their class and have the potential to change treatment strategies of diseases. The shares of Herantis Pharma plc. are listed on the First North Finland marketplace run by NASDAQ OMX Helsinki stock exchange.